高E2F7表达表明胰腺癌的攻击性和下调E2F7提高对S-1的敏感性

Keizo Fujita1, Yukiyasu Okamura2, Masamichi Hayashi3

  • 1Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Annals of surgical oncology
|December 26, 2025
PubMed
概括

在胰腺癌中E2F7mRNA表达预测了患者的存活率和对S-1化疗的反应. 与gemcitabine相比,较低的E2F7水平表明S-1治疗的预后更好.